Steven Feldman to Scalp Dermatoses
This is a "connection" page, showing publications Steven Feldman has written about Scalp Dermatoses.
Connection Strength
2.207
-
Hill D, Farhangian ME, Feldman SR. Increasing adherence to topical therapy in psoriasis through use of solution medication. Dermatol Online J. 2016 May 15; 22(5).
Score: 0.533
-
Feldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan R. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs. J Med Econ. 2013 Dec; 16(12):1405-13.
Score: 0.446
-
Feldman SR, Mills M, Brundage T, Eastman WJ. A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp. J Drugs Dermatol. 2013 Mar; 12(3):300-6.
Score: 0.427
-
West C, Narahari S, Kwatra S, Feldman S. Autosomal dominant transmission of nevus sebaceous of Jadassohn. Dermatol Online J. 2012 Nov 15; 18(11):17.
Score: 0.418
-
Callender VD, Young CM, Haverstock CL, Carroll CL, Feldman SR. An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. Cutis. 2005 Jun; 75(6):317-21.
Score: 0.250
-
Kin KC, Hill D, Feldman SR. Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis. Expert Rev Clin Pharmacol. 2016 Jun; 9(6):789-97.
Score: 0.133